Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
Bio-Rad Diabetes Division
PURITAN MEDICAL

Elevated Blood Eosinophil Levels Predict Asthma Exacerbations

By Labmedica International staff writers
Posted on 05 Jun 2014
Image: Blood film showing five active eosinophils with a multisegmented nucleus and numerous eosinophilic granules (Photo courtesy of American Academy of Pediatrics).
Image: Blood film showing five active eosinophils with a multisegmented nucleus and numerous eosinophilic granules (Photo courtesy of American Academy of Pediatrics).
In adults with persistent asthma, elevated blood eosinophil levels may be able to predict which individuals are at increased risk for exacerbations.

Eosinophils are white blood cells that become active in individuals with certain allergic diseases, including asthma, and other medical conditions such as parasitic infections.

Physicians at Kaiser Permanente (San Diego, CA, USA) measured blood eosinophil level in 2,392 adult asthma patients in 2010 and the relationship between these levels and the rate of exacerbations in 2011 was determined in analyses adjusting for demographics, comorbidities, and asthma burden and care.

The scientists found that increasing level of blood eosinophil at baseline was associated with increasing risk of future asthma exacerbation in both crude and adjusted analyses. The relationship was observed in crude analysis for baseline eosinophil level of greater than 300/mm3 with crude rate ratio 1.25, but was weaker after adjustment for baseline characteristics with an adjusted rate ratio 1.16.

In 2011, after adjustment for baseline features, the adjusted rate ratio of 1.31, which was highly significant, the authors concluded that a baseline eosinophil level of greater than 400/mm3 was associated with future asthma exacerbations. Other factors in 2010 that were significantly associated with an increased risk of exacerbations in 2011 included a history of prior asthma exacerbations, Global Initiative for Asthma (GINA) steps-4/5, dispensing of seven or more short-acting beta-agonist canisters, female gender, black ethnicity, and obesity.

Robert S. Zeiger, MD, PhD, the Physician Investigator at Kaiser Permanente, said, “Eosinophils are known to be involved in the pathophysiology of asthma, and determining their relationship with asthma exacerbations may allow us to determine in advance which of these patients needs targeted interventions. In our study, elevated blood eosinophil levels were found to be a risk factor for subsequent exacerbations in adult asthma patients”.

Dr. Zeiger added “Our findings suggest that asthma patients with an elevated blood eosinophil level have a greater disease burden. If our findings can be replicated in other populations and settings, measurement of blood eosinophil levels may help guide treatment for patients at the greatest risk for exacerbations.” The study was presented at the American Thoracic Society International Conference, held May 16–21, 2014, in San Diego (CA, USA).

Related Links:

Kaiser Permanente




ADVANCED INSTRUMENTS
KARL HECHT GMBH & CO KG
DIASYS DIAGNOSTIC SYSTEMS
WATERS CORPORATION

Channels

Genetic Tests

view channel

Overexpression of X Chromosome Genes Is Biomarker for Female Mental Disorders

A recent paper suggested that elevated expression of the genes XIST (X-inactive specific transcript) and KDM5C (lysine-specific demethylase 5C) could be used as a biological marker for diagnosis of major affective disorders in a significantly large subset of female patients from the general population. Xist is an RNA... Read more

Immunology

view channel

Powerful Innovations in Diagnostics Unveiled at EuroMedLab 2015

New systems presented by Roche include a new standard for immunology testing, an integrated platform for hematology diagnostics, and a high-throughput analyzer to perform HbA1c tests for blood glucose management. Also, evidence was presented for a high-sensitivity cardiac troponin test to provide earlier and more accurate... Read more

Industry News

view channel

Hitachi High-Tech and QIAGEN Partner to Advance Diagnostics

Hitachi High-Technologies Corporation (Tokyo, Japan) and QIAGEN N.V. (Venlo, The Netherlands) have entered into a long-term strategic collaboration involving initiatives to deliver important advances in molecular testing. Under terms of the agreement both companies will bring their unique strengths to the collaboration:... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.